peptide-solutions
SEMAGLUTIDE
GLP-1 receptor agonist for metabolic research
Research Compound
Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.
Semaglutide is a GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. Research continues to explore cardiovascular, renal, and neurological benefits.
Compound Specifications
Scientific Documentation
Research Reference
Detailed research information, pharmacological profile, and handling specifications
Mechanism of Action
GLP-1R agonism stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and activates hypothalamic satiety centers. C-18 fatty acid modification enables albumin binding.
Research Use Only Disclaimer
This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.
Related Compounds
Other research peptides you may be interested in
TIRZEPATIDE
Dual GLP-1/GIP receptor agonist for metabolic research
from $104
RETATRUTIDE
Triple-action GLP-1/GIP/Glucagon receptor agonist
from $125
TESAMORELIN 10MG
GHRH analog for metabolic and body composition research
$65